-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Lmucpo8dJXdd/Oouzs/QB+qxL5a3k93Zgs0Ke14TV2A9j21fIPcrgPw5Q0TF24lJ rlw8Iag2yQ78hmaE4PSh6w== 0000947871-10-000973.txt : 20101005 0000947871-10-000973.hdr.sgml : 20101005 20101005151157 ACCESSION NUMBER: 0000947871-10-000973 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20101001 FILED AS OF DATE: 20101005 DATE AS OF CHANGE: 20101005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUN PHARMA GLOBAL INC CENTRAL INDEX KEY: 0001197088 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-22286 FILM NUMBER: 101108992 BUSINESS ADDRESS: STREET 1: SPARC AKOTA ROAD CITY: VADODARA STATE: A1 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUN PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0001197089 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-22286 FILM NUMBER: 101108993 BUSINESS ADDRESS: STREET 1: SPARC AKOTA ROAD CITY: VADODARA STATE: K7 ZIP: 390020 BUSINESS PHONE: 01191228212128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TARO PHARMACEUTICAL INDUSTRIES LTD CENTRAL INDEX KEY: 0000906338 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14 HAKTOR ST CITY: HAIFA BAY STATE: L3 ZIP: 26110 BUSINESS PHONE: 9143459001 MAIL ADDRESS: STREET 1: THREE SKYLINE DR CITY: HAWTHORNE STATE: NY ZIP: 10532 FORMER COMPANY: FORMER CONFORMED NAME: TARO VIT INDUSTRIES LTD /ISRAEL/ DATE OF NAME CHANGE: 19930601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alkaloida Chemical CO Exclusive Group Ltd. CENTRAL INDEX KEY: 0001438382 STATE OF INCORPORATION: K5 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-22286 FILM NUMBER: 101108991 BUSINESS ADDRESS: STREET 1: KABAY JANOS UT 29. CITY: TISZAVASVARI STATE: K5 ZIP: 4440 BUSINESS PHONE: 36.42.521.005 MAIL ADDRESS: STREET 1: KABAY JANOS UT 29. CITY: TISZAVASVARI STATE: K5 ZIP: 4440 4/A 1 ss102030_4a.xml X0303 4/A 2010-10-01 2010-09-29 0 0000906338 TARO PHARMACEUTICAL INDUSTRIES LTD TAROF 0001197089 SUN PHARMACEUTICAL INDUSTRIES LTD 17/B, MAHAL INDUSTRIAL ESTATE MAHAKALI CAVES ROAD, ANDHERI (EAST) MUMBAI, K7 400 093 INDIA 0 0 1 1 Affiliated Party 0001197088 SUN PHARMA GLOBAL INC INTERNATIONAL TRUST BUILDING P.O. BOX 659 ROAD TOWN, TORTOLA D8 VIRGIN ISLANDS, BRITISH 0 0 1 1 Affiliated Party 0001438382 Alkaloida Chemical CO Exclusive Group Ltd. KABAY JANOS U. 29. H-4440 TISZAVASVARI, K5 4440 HUNGARY 0 0 1 1 Affiliated Party Ordinary Shares 2010-10-01 4 P 0 2333922 A 9338168 I See Footnote Equivalent to Common Stock. All Ordinary Shares of Taro Pharmaceutical Industries Ltd. (the "Issuer") control in the aggregate two-thirds of the voting power of the Issuer. Upon the merger of a subsidiary of Sun Pharmaceutical Industries Inc. ("Sun Michigan"), a Michigan corporation and a direct subsidiary of Sun Pharmaceutical Industries Ltd. ("Sun") with and into The Taro Development Corporation ("TDC") on October 1, 2010, for an aggregate consideration of approximately $18.1 million, Sun Michigan indirectly acquired 2,333,922 Ordinary Shares, consummating an option granted by TDC to Alkaloida Chemical Company Exclusive Group Ltd. ("Alkaloida"), an indirect subsidiary of Sun (and subsequently assigned to Sun Michigan) under an Option Agreement, dated May 17, 2007, among Sun, TDC, Dr. Barrie Levitt, Ms. Tal Levitt, Dr. Jacob Levitt, and Daniel Moros (such individuals, together with TDC, the "Grantors"). TDC directly owns 2,333,142 Ordinary Shares and indirectly owns 780 Ordinary Shares through Morley and Company, Inc., a New York corporation owned by TDC and Alkaloida. This amount represents 58,000 Ordinary Shares acquired by Sun Pharma Global, Inc. ("Sun Pharma"), a direct wholly-owned subsidiary of Sun, on July 11, 2007 and 500 Ordinary Shares acquired by Sun Pharma on July 23, 2007, in each case in open market transactions; 3,712,557 Ordinary Shares acquired by Alkaloida on February 19, 2008 from Brandes Investment Partners, L.P., for and on behalf of certain of its investment advisory clients; 797,870 Ordinary Shares acquired by Alkaloida on June 23, 2008 from Harel Insurance Company Limited; 29,382 Ordinary Shares acquired by Alkaloida on September 14, 2010 upon the expiration of the tender offer to acquire all of Issuer's outstanding Ordinary Shares, commenced on June 30, 2008; 2,405,937 Ordinary Shares acquired pursuant to a letter agreement, dated as of September 20, 2010, among Sun, Alkaloida, Sun Michigan and the Grantors; and 2,333,922 Ordinary Shares referenced in footnote 2. In addition, Sun indirectly owns 13,575,000 Ordinary Shares which are restricted stock consisting of: (i) 3,770,833 Ordinary Shares acquired by Alkaloida, on May 21, 2007 and 3,016,667 Ordinary Shares acquired by Alkaloida on May 30, 2007, in each case pursuant to the share purchase agreement dated May 18, 2007, between Alkaloida and the Issuer, which entitled Alkaloida to acquire a total of 7,500,000 Ordinary Shares; (ii) 3,000,000 Ordinary Shares acquired by Alkaloida on August 2, 2007, pursuant to Sun's rights under the warrant, dated May 18, 2007, issued by the Issuer to Sun, and (iii) 3,712,500 Ordinary Shares acquired by Alkaloida on September 24, 2010 and 75,000 Ordinary Shares acquired by Alkaloida on September 27, 2010, in each case pursuant to a warrant dated August 2, 2007, between Sun and the Issuer. /s/ Sailesh T. Desai, Director of Sun Pharmaceutical Industries Ltd. 2010-10-05 /s/ Harin Mehta, Managing Director of Sun Pharma Global, Inc. 2010-10-05 /s/ Harin Mehta, Managing Director of Alkaloida Chemical Company Exclusive Group Ltd. 2010-10-05 EX-99.1 2 ss102030_ex9901.htm JOINT FILER INFORMATION
Exhibit 99.1

Form 4 Joint Filer Information

 
Name:  Sun Pharma Global Inc.
 
Address:  Registered Office:
 
International Trust Building
 
P.O. Box 659
 
Road Town, Tortola, British Virgin Islands
 
Office at Woodstock Asia Pascific DMCC,
Office No. 406
The Business Centre, Opp. Burjuman Centre,
Mashreq Bank Bldg.
Bank Street, P.O. Box 12850, Dubai, U.A.E.
 
Designated Filer: Sun Pharmaceutical Industries Ltd.
 
Issuer and Ticker Symbol:  Taro Pharmaceutical Industries Ltd. (“TAROF”)
 
Date of Event Requiring Statement:  10/05/2010

Signature: By:
 /s/ Harin Mehta
  
 
Harin Mehta, Managing Director of
  
 
Sun Pharma Global, Inc.
  
 

 
Name:  Alkaloida Chemical Company Exclusive Group Ltd.
 
Address:  Kabay János u. 29, H-4440 Tiszavasari,
 
The Republic of Hungary
 
Designated Filer: Sun Pharmaceutical Industries Ltd.
 
Issuer and Ticker Symbol:  Taro Pharmaceutical Industries Ltd. (“TAROF”)
 
Date of Event Requiring Statement:  10/05/2010

Signature: By:
 /s/ Harin Mehta
  
 
 Harin Mehta, Director of
  
 
Alkaloida Chemical Company Exclusive Group Ltd.
 
 
 

 -----END PRIVACY-ENHANCED MESSAGE-----